StockData
Connect Biopharma Holdings Ltd logo

Connect Biopharma Holdings Ltd (CNTB) stock

CNTBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/30
$0.58−0.06 (-9.98%)

Close on Nov 17, 2026Market cap $36.45MP/E –Yield –

Connect Biopharma profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Connect Biopharma's profit margin for the twelve months ending Jun 30, 2026 was -2336.3%. For fiscal 2025 it was -86687.5%, against -60.0% the year before.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-86687.5%−86627.5
FY2024Dec 31, 2024-60.0%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 2026-624.4%+651.5
Q1 FY2026Mar 31, 2026-11478.1%−10421.8
Q3 FY2025Sep 30, 2025-107500.0%−107561.6
Q2 FY2025Jun 30, 2025-26872.9%–
Q4 FY2024Dec 31, 2024-1275.9%–
Q3 FY2024Sep 30, 2024-1056.3%–
Q2 FY2024Jun 30, 202461.6%–

More Connect Biopharma figures

See a number that looks wrong?